“…The MICU1 protein functions as a calcium uniporter protein and is responsible for delivering calcium ions to the mitochondrial matrix [5]. Pathogenic variants in MICU1 manifest phenotypically with multisystem disease affecting the skeletal muscles (proximal myopathy, ptosis, ophthalmoparesis, dysarthria, scapula alata), the brain (cognitive impairment, mental retardation, attention deficit, depression, insomnia, seizures, extrapyramidal abnormalities (chorea, dystonia, athetosis, tremor, orofacial dyskinesia, tics), ataxia, nystagmus, dysarthria, polymicrogyria, dysmorphic basal ganglia, hypoplastic anterior limbs of internal capsules, cerebellar dysplasia, optic atrophy), the peripheral nerves (axonal neuropathy), the heart (dilated cardiomyopathy), the skeleton (microcephaly, hypertelorism, high arched palate, pes cavus, clinodactyly, hyperlordosis, hyperkyphosis, radioulnar synostosis, low-set ears), the endocrine organs (short stature, hypothyroidism), and the eyes (cataract) [5][6][7][8][9][10][11][12][13][14][15][16]. The most common phenotype is an autosomal recessive, childhood-onset myopathy with proximal muscle weakness with extrapyramidal signs (MPXPS) (OMIM #615673) [15].…”